Biogen Inc (NAS:BIIB)
$ 234.13 4.33 (1.88%) Market Cap: 34.09 Bil Enterprise Value: 39.33 Bil PE Ratio: 29.23 PB Ratio: 2.23 GF Score: 68/100

Biogen Inc Pre-Recorded Presentation of Cerebrospinal Fluid Biomarker Concordance with Amyloid PET in EMERGE and ENGAGE at AD/PD Transcript

Mar 10, 2021 / 11:45AM GMT
Release Date Price: $262.61 (-1.46%)
Laura Nisenbaum

Presentation of Cerebrospinal Fluid Biomarker Concordance with Amyloid PET in EMERGE and ENGAGE at AD/PD
Mar 10, 2021 / 11:45AM GMT

=====================
Corporate Participants
=====================
* Laura Nisenbaum

=====================
-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot